CollabRx (CLRX) climbs higher before the bell after announcing genetic diagnostics firm Sengenics will incorporate CLRX's interpretive analytics into its cancer diagnostic tests. Shares +10.75% premarket.
CollabRx (CLRX) climbs higher before the bell after announcing genetic diagnostics firm...
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs